glp-1 plans If you're covered by the State Health Benefit Plan (SHBP) and take a weight-loss medication (like Wegovy or Zepbound), a change is coming. Starting February 1, 2026, SHBP will require these Long-term Success of GLP-1s Hinges

Meng M, Jiang Y, Wang Y, Huo R, Ma N, Shen X, Chang G

zellikle salkl bireylerde ve yeterli LKarnitin dzeyine sahip kiilerde yaplan almalarda, performans ya da ya yakm zerine belirgin bir etkisi gzlenmemitir

Xianchu L, Kang L, Beiwan D, Huan P, Ming L

This dual mechanism of action may make Zepbound one of the most effective among the newly available weight loss medications

It is important to note that direct clinical activity remains relatively limited and this gap underscores the need for translational research

The anti-fibrotic effects of GLP-1RAs may arise from their ability to improve metabolic control, reduce body weight, and directly affect HSCs